Skip to content

Friedreich Ataxia Nerve Ultrasund

Friedreich Ataxia Nerve Ultrasund and Clinical Correlations

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07508631
Acronym
FAUST
Enrollment
14
Registered
2026-04-02
Start date
2025-12-01
Completion date
2026-04-30
Last updated
2026-04-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Friedreich Ataxia

Brief summary

"Friedreich ataxia is the most common inherited autosomal recessive ataxia. It is caused by a GAA repeat expansion in the frataxin gene on chromosome 9q21.11. Symptoms usually begin in childhood, typically between 9 and 13 years of age. The disease leads to progressive damage of the nervous system and the heart, as well as multisystem involvement of various degrees, leading to diabetes, vision and hearing loss and scoliosis. Over time, most patients lose the ability to walk and require a wheelchair, often by their mid-twenties. The severity and progression of the disease can vary depending on various factors such as the age at onset and the size of the GAA triplet expansion. Traditionally, Friedreich ataxia has been considered a disorder primarily affecting nerve cells, also called neuronopathy. However, recent studies using ultrasound imaging of peripheral nerves have shown that some nerves may appear enlarged, particularly in the upper limbs. This is in contrast with findings usually observed in other neuronopathies, where peripheral nerves tend to become thinner. The aim of this study is to use nerve ultrasound to better understand changes in intraneural vascularization and nerve in patients with Friedreich ataxia. In particular, we assess the presence of intraneural blood flow within the nerves using a high-resolution ultrasound technique. The study includes 13 patients with genetically confirmed Friedreich ataxia who are followed at the Neurogenetics Competence Center of Nice University Hospital. Ultrasound examinations are performed on the median and ulnar nerves at standardized locations: for median nerve at wrist, forearm (10 cm from the distal wrist crease), antecubital fossa, mid-arm and axilla; for ulnar nerve at the wrist, forearm (10 cm from the pisiform bone), at the elbow (5 cm below and above the elbow), mid-arm and axilla; the brachial plexus is measured at level C5, C6, C7. In addition to vascularization, we also measure nerve size (cross-sectional area) and evaluate internal nerve structure. This study aims to improve understanding of nerve involvement in Friedreich ataxia and to explore whether ultrasound could provide useful markers of disease severity."

Interventions

DIAGNOSTIC_TESTNerve ultrasound - routine exam

Nerve ultrasound is a widely used imaging modality in clinical practice. It allows for the measurement of nerve cross-sectional area and provides detailed visualization of internal fascicular architecture and vascularization. These features can offer indirect information about underlying nerve pathology, such as inflammation or structural damage. Reference values have been established for different segments of the median and ulnar nerves, as well as for the brachial plexus

Sponsors

Centre Hospitalier Universitaire de Nice
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Patients aged between 18 and 70 years. * Genetically confirmed diagnosis of Friedreich's Ataxia. * Followed at the Neurogenetics Competence Centre, CHU Nice. * Have undergone peripheral nerve ultrasound between December 2025 and April 2026.

Exclusion criteria

* Patients for whom peripheral nerve ultrasound data is unavailable.

Design outcomes

Primary

MeasureTime frameDescription
Ultrasound assessement of intraneural vascularisationAt the inclusionAssessement of intraneural vascularisation by Doppler ultrasound 30 mn (composite criterion : clinical data, imaging data)

Secondary

MeasureTime frameDescription
Ultrasound assessement of peripheral nerve cross sectional area at predefined sitesAt the inclusionCross sectional area ultrasound measurement in mm of median nerve at wrist, forearm (10 cm from the distal wrist crease), antecubital fossa, mid-armmedian and ulnar nerves at wrist, forearm, mid - arm and ulnar nerve at the wrist, forearm (10 cm from the pisiform bone), at the elbow (5 cm below and above the elbow), mid-arm and axilla. The brachial plexus was measured at level C5, C6, C7 30 minutes (composite criterion : clinical data, imaging data)
Ultrasound assessement of peripheral nerve internal structure at predefined sitesAt the inclusionUltrasound assessement of peripheral nerve echogenicity defined as hypo/hyperechogenic and internal fascicular disposition defined as preserved / loss of internal fascicular pattern (composite criterion : clinical data, imaging data)

Countries

France

Contacts

CONTACTAndra Ezaru
ezaru.a@chu-nice.fr07 80 65 10 81
CONTACTAngela Puma
puma.ar@chu-nice.fr07 62 25 40 17

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 3, 2026